当前位置：
X-MOL 学术
›
Immun. Ageing
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?
Immunity & Ageing ( IF 5.2 ) Pub Date : 2020-06-30 , DOI: 10.1186/s12979-020-00192-y Caio Henrique Mazucanti 1 , Josephine Mary Egan 1
Immunity & Ageing ( IF 5.2 ) Pub Date : 2020-06-30 , DOI: 10.1186/s12979-020-00192-y Caio Henrique Mazucanti 1 , Josephine Mary Egan 1
Affiliation
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel virus responsible for the current coronavirus disease 2019 (COVID-19) pandemic, has infected over 3.5 million people all over the world since the first case was reported from Wuhan, China 5 months ago. As more epidemiological data regarding COVID-19 patients is acquired, factors that increase the severity of the infection are being identified and reported. One of the most consistent co-morbidities associated with worse outcome in COVID-19 patients is diabetes, along with age and cardiovascular disease. Studies on the association of diabetes with other acute respiratory infections, namely SARS, MERS, and Influenza, outline what seems to be an underlying factor in diabetic patients that makes them more susceptible to complications. In this review we summarize what we think may be the factors driving this pattern between diabetes, aging and poor outcomes in respiratory infections. We also review therapeutic considerations and strategies for treatment of COVID-19 in diabetic patients, and how the additional challenge of this co-morbidity requires attention to glucose homeostasis so as to achieve the best outcomes possible for patients.
更新日期：2020-06-30
京公网安备 11010802027423号